New York, NY -- (SBWIRE) -- 01/21/2014 -- Shares of Ligand Pharmaceuticals Inc.(NASDAQ:LGND) are trading at $64.26 and is +16.20% from its 50-day Moving Average price of $55.3024 and +29.77% from its 200-day Moving Average price of $49.5167. The average trading volume is 349489 shares and its market capitalization is $1.312B. Ligand Pharmaceuticals Incorporated is a biotechnology company that operates with a business model focused on developing or acquiring assets. The Company’s technology portfolio CAPTISOL is a formulation technology that has enabled five Food and Drug Administration (FDA) approved products, including Pfizer’s VFEND IV and Baxter International’s Nexterone and is being used in a number of clinical-stage partner programs.